These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

928 related items for PubMed ID: 1900308

  • 21. Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.
    Weitz JI, Leslie B, Hirsh J, Klement P.
    J Clin Invest; 1993 Apr; 91(4):1343-50. PubMed ID: 7682569
    [Abstract] [Full Text] [Related]

  • 22. [Plasminogen-binding centers of molecules of fibrinogen, fibrin and products of their proteolysis].
    Grinenko TV, Tret'iachenko VG, Kudinov SA, Medved' LV.
    Biokhimiia; 1987 Oct; 52(10):1732-9. PubMed ID: 3427134
    [Abstract] [Full Text] [Related]

  • 23. Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots.
    Tran-Thang C, Kruithof EK, Bachmann F.
    J Clin Invest; 1984 Dec; 74(6):2009-16. PubMed ID: 6210307
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
    Grailhe P, Boyer-Neumann C, Haverkate F, Grimbergen J, Larrieu MJ, Anglés-Cano E.
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ, Eisenberg PR, Abendschein DR.
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator (t-PA) and fibrin-dependent enhancement of amidolytic activity of t-PA.
    Fischer BE.
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):197-204. PubMed ID: 1606292
    [Abstract] [Full Text] [Related]

  • 29. Clot lysis induced by a monoclonal antibody against alpha 2-plasmin inhibitor.
    Sakata Y, Eguchi Y, Mimuro J, Matsuda M, Sumi Y.
    Blood; 1989 Dec; 74(8):2692-7. PubMed ID: 2510836
    [Abstract] [Full Text] [Related]

  • 30. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R, Black J, Gurewich V.
    J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
    [Abstract] [Full Text] [Related]

  • 31. Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.
    Stewart RJ, Fredenburgh JC, Rischke JA, Bajzar L, Weitz JI.
    J Biol Chem; 2000 Nov 24; 275(47):36612-20. PubMed ID: 10970891
    [Abstract] [Full Text] [Related]

  • 32. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA, Leonova VB, Khavkina LS.
    Izv Akad Nauk SSSR Biol; 1991 Nov 24; (3):334-42. PubMed ID: 1835465
    [Abstract] [Full Text] [Related]

  • 33. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
    Kamijyo Y, Hirota-Kawadobora M, Yamauchi K, Terasawa F, Honda T, Ikeya M, Okumura N.
    Blood Coagul Fibrinolysis; 2009 Dec 24; 20(8):726-32. PubMed ID: 19809304
    [Abstract] [Full Text] [Related]

  • 34. [PC-12 cells hydrolyze the fibrin clot by producing both plasminogen and its tissue activator].
    Petrova IuI, Savchuk OM, Kalashnyk OM, Platonova TM, Skok MV, Cederholm-Williams S.
    Ukr Biokhim Zh (1999); 2004 Dec 24; 76(2):64-8. PubMed ID: 15915713
    [Abstract] [Full Text] [Related]

  • 35. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ, Stafford AR, Leslie BA, Kim PY, Vaezzadeh N, Ni R, Fredenburgh JC, Weitz JI.
    Thromb Haemost; 2015 Jun 24; 113(6):1278-88. PubMed ID: 25789495
    [Abstract] [Full Text] [Related]

  • 36. Binding of fibrin fragments to one-chain and two-chain tissue-type plasminogen activator.
    Hasan AA, Chang WS, Budzynski AZ.
    Blood; 1992 May 01; 79(9):2313-21. PubMed ID: 1571544
    [Abstract] [Full Text] [Related]

  • 37. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A, Markart P, Kalinowski M, Ruppert C, Grimminger F, Seeger W.
    Am J Respir Cell Mol Biol; 1999 Dec 01; 21(6):738-45. PubMed ID: 10572071
    [Abstract] [Full Text] [Related]

  • 38. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR, Jaffe AS, Stump DC, Collen D, Bovill EG.
    Circulation; 1990 Oct 01; 82(4):1159-68. PubMed ID: 2119264
    [Abstract] [Full Text] [Related]

  • 39. [Proteolytic activity of the Glu-plasminogen complex with fibrinogen fragment E].
    Skomorovskaia EV, Grinenko TV, Kudinov SA, Zolotareva EN.
    Biokhimiia; 1991 Mar 01; 56(3):458-66. PubMed ID: 1883906
    [Abstract] [Full Text] [Related]

  • 40. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
    Kwasny-Krochin B, Gluszko P, Undas A.
    Thromb Res; 2010 Jul 01; 126(1):e11-6. PubMed ID: 20471669
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.